The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 23,770,486 | 1,493,121 | SH | SOLE | NONE | 1,493,121 | 0 | 0 | |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 37,705,264 | 2,393,985 | SH | SOLE | NONE | 2,393,985 | 0 | 0 | |
| ALECTOR INC | COM | 014442107 | 6,691,972 | 725,024 | SH | SOLE | NONE | 725,024 | 0 | 0 | |
| ALIGN TECHNOLOGY INC | COM | 016255101 | 46,383,237 | 219,930 | SH | SOLE | NONE | 219,930 | 0 | 0 | |
| ALLAKOS INC | COM | 01671P100 | 7,748,960 | 920,304 | SH | SOLE | NONE | 920,304 | 0 | 0 | |
| ALPHATEC HLDGS INC | NOTE 0.750% 8/0 | 02081GAB8 | 103,135,300 | 112,250,000 | PRN | SOLE | NONE | 112,250,000 | 0 | 0 | |
| ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 2,910,816 | 258,280 | SH | SOLE | NONE | 258,280 | 0 | 0 | |
| AMGEN INC | COM | 031162100 | 34,432,104 | 131,100 | SH | SOLE | NONE | 131,100 | 0 | 0 | |
| AMYRIS INC | NOTE 1.500%11/1 | 03236MAJ0 | 43,250,438 | 137,850,000 | PRN | SOLE | NONE | 137,850,000 | 0 | 0 | |
| ANAPTYSBIO INC | COM | 032724106 | 22,502,521 | 726,122 | SH | SOLE | NONE | 726,122 | 0 | 0 | |
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 20,146,009 | 389,596 | SH | SOLE | NONE | 389,596 | 0 | 0 | |
| ARGENX SE | SPONSORED ADR | 04016X101 | 18,638,436 | 49,200 | SH | SOLE | NONE | 49,200 | 0 | 0 | |
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 33,804,701 | 4,112,494 | SH | SOLE | NONE | 4,112,494 | 0 | 0 | |
| BIOGEN INC | COM | 09062X103 | 69,933,931 | 252,542 | SH | SOLE | NONE | 252,542 | 0 | 0 | |
| BIOMARIN PHARMACEUTICAL INC | NOTE 0.599% 8/0 | 09061GAH4 | 9,574,200 | 9,000,000 | PRN | SOLE | NONE | 9,000,000 | 0 | 0 | |
| BIOMARIN PHARMACEUTICAL INC | NOTE 1.250% 5/1 | 09061GAK7 | 20,727,568 | 19,200,000 | PRN | SOLE | NONE | 19,200,000 | 0 | 0 | |
| BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | 10806XAD4 | 16,151,021 | 42,294,000 | PRN | SOLE | NONE | 42,294,000 | 0 | 0 | |
| BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 63,675,000 | 141,500,000 | PRN | SOLE | NONE | 141,500,000 | 0 | 0 | |
| COMPASS THERAPEUTICS INC | COM | 20454B104 | 9,125,758 | 1,814,266 | SH | SOLE | NONE | 1,814,266 | 0 | 0 | |
| COOPER COS INC | COM NEW | 216648402 | 17,232,867 | 52,115 | SH | SOLE | NONE | 52,115 | 0 | 0 | |
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 63,495,034 | 3,469,674 | SH | SOLE | NONE | 3,469,674 | 0 | 0 | |
| DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 26,825,519 | 1,246,539 | SH | SOLE | NONE | 1,246,539 | 0 | 0 | |
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 18,524,911 | 12,107,785 | SH | SOLE | NONE | 12,107,785 | 0 | 0 | |
| DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 53,620,098 | 3,271,513 | SH | SOLE | NONE | 3,271,513 | 0 | 0 | |
| DICE THERAPEUTICS INC | COM | 23345J104 | 26,179,140 | 839,075 | SH | SOLE | NONE | 839,075 | 0 | 0 | |
| DYNE THERAPEUTICS INC | COM | 26818M108 | 8,728,951 | 753,145 | SH | SOLE | NONE | 753,145 | 0 | 0 | |
| EDWARDS LIFESCIENCES CORP | COM | 28176E108 | 17,557,151 | 235,319 | SH | SOLE | NONE | 235,319 | 0 | 0 | |
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 15,157,984 | 325,838 | SH | SOLE | NONE | 325,838 | 0 | 0 | |
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 21,140,913 | 3,393,405 | SH | SOLE | NONE | 3,393,405 | 0 | 0 | |
| EXACT SCIENCES CORP | NOTE 0.375% 3/0 | 30063PAC9 | 109,643,200 | 139,000,000 | PRN | SOLE | NONE | 139,000,000 | 0 | 0 | |
| EXACT SCIENCES CORP | NOTE 0.375% 3/1 | 30063PAB1 | 40,089,000 | 48,300,000 | PRN | SOLE | NONE | 48,300,000 | 0 | 0 | |
| FUSION PHARMACEUTICALS INC | COM | 36118A100 | 6,300,000 | 2,000,000 | SH | SOLE | NONE | 2,000,000 | 0 | 0 | |
| GLAUKOS CORP | COM | 377322102 | 72,589,652 | 1,661,851 | SH | SOLE | NONE | 1,661,851 | 0 | 0 | |
| GLOBUS MED INC | CL A | 379577208 | 25,521,103 | 343,626 | SH | SOLE | NONE | 343,626 | 0 | 0 | |
| GUARDANT HEALTH INC | NOTE 11/1 | 40131MAB5 | 156,738,792 | 250,022,000 | PRN | SOLE | NONE | 250,022,000 | 0 | 0 | |
| HILLEVAX INC | COM | 43157M102 | 27,106,214 | 1,620,216 | SH | SOLE | NONE | 1,620,216 | 0 | 0 | |
| IMMATICS N.V | SHS | N44445109 | 10,887,953 | 1,250,052 | SH | SOLE | NONE | 1,250,052 | 0 | 0 | |
| IMMUNOGEN INC | COM | 45253H101 | 17,233,505 | 3,474,497 | SH | SOLE | NONE | 3,474,497 | 0 | 0 | |
| INSMED INC | NOTE 0.750% 6/0 | 457669AB5 | 8,300,000 | 10,000,000 | PRN | SOLE | NONE | 10,000,000 | 0 | 0 | |
| INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 37,665,128 | 399,630,000 | PRN | SOLE | NONE | 399,630,000 | 0 | 0 | |
| INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 59,204,892 | 223,120 | SH | SOLE | NONE | 223,120 | 0 | 0 | |
| INVITAE CORP | NOTE 2.000% 9/0 | 46185LAB9 | 17,038,830 | 21,500,000 | PRN | SOLE | NONE | 21,500,000 | 0 | 0 | |
| IONIS PHARMACEUTICALS INC | NOTE 4/0 | 462222AD2 | 48,949,313 | 52,740,000 | PRN | SOLE | NONE | 52,740,000 | 0 | 0 | |
| IONIS PHARMACEUTICALS INC | NOTE 0.125%12/1 | 462222AB6 | 33,358,282 | 36,533,000 | PRN | SOLE | NONE | 36,533,000 | 0 | 0 | |
| IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 46,616,468 | 497,667 | SH | SOLE | NONE | 497,667 | 0 | 0 | |
| ITEOS THERAPEUTICS INC | COM | 46565G104 | 1,398,055 | 71,585 | SH | SOLE | NONE | 71,585 | 0 | 0 | |
| IVERIC BIO INC | COM | 46583P102 | 71,537,233 | 3,341,300 | SH | SOLE | NONE | 3,341,300 | 0 | 0 | |
| KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 49,369,841 | 65,976,000 | PRN | SOLE | NONE | 65,976,000 | 0 | 0 | |
| KODIAK SCIENCES INC | COM | 50015M109 | 6,545,736 | 914,209 | SH | SOLE | NONE | 914,209 | 0 | 0 | |
| KRYSTAL BIOTECH INC | COM | 501147102 | 28,365,196 | 358,056 | SH | SOLE | NONE | 358,056 | 0 | 0 | |
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 32,852,402 | 658,101 | SH | SOLE | NONE | 658,101 | 0 | 0 | |
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 10,915,422 | 1,862,700 | SH | SOLE | NONE | 1,862,700 | 0 | 0 | |
| MERUS N V | COM | N5749R100 | 30,910,360 | 1,998,084 | SH | SOLE | NONE | 1,998,084 | 0 | 0 | |
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 4,612,802 | 1,164,849 | SH | SOLE | NONE | 1,164,849 | 0 | 0 | |
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 18,740,216 | 413,600 | SH | SOLE | NONE | 413,600 | 0 | 0 | |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 4,001,760 | 381,120 | SH | SOLE | NONE | 381,120 | 0 | 0 | |
| NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 | 63009RAD1 | 118,195,691 | 145,520,000 | PRN | SOLE | NONE | 145,520,000 | 0 | 0 | |
| NATERA INC | COM | 632307104 | 65,116,052 | 1,621,012 | SH | SOLE | NONE | 1,621,012 | 0 | 0 | |
| NEKTAR THERAPEUTICS | COM | 640268108 | 1,401,833 | 620,280 | SH | SOLE | NONE | 620,280 | 0 | 0 | |
| NEOGENOMICS INC | NOTE 0.250% 1/1 | 64049MAB6 | 31,947,371 | 48,678,000 | PRN | SOLE | NONE | 48,678,000 | 0 | 0 | |
| NEOGENOMICS INC | NOTE 1.250% 5/0 | 64049MAA8 | 8,481,250 | 10,000,000 | PRN | SOLE | NONE | 10,000,000 | 0 | 0 | |
| NEOGENOMICS INC | NOTE 1.250% 5/0 | 64049MAA8 | 27,988,125 | 33,000,000 | PRN | SOLE | NONE | 33,000,000 | 0 | 0 | |
| NEVRO CORP | COM | 64157F103 | 47,215,001 | 1,192,298 | SH | SOLE | NONE | 1,192,298 | 0 | 0 | |
| NEVRO CORP | NOTE 2.750% 4/0 | 64157FAC7 | 100,237,793 | 109,251,000 | PRN | SOLE | NONE | 109,251,000 | 0 | 0 | |
| NKARTA INC | COM | 65487U108 | 9,139,542 | 1,525,800 | SH | SOLE | NONE | 1,525,800 | 0 | 0 | |
| NOVOCURE LTD | NOTE 11/0 | 67011XAB9 | 117,582,745 | 131,834,000 | PRN | SOLE | NONE | 131,834,000 | 0 | 0 | |
| NUVASIVE INC | NOTE 0.375% 3/1 | 670704AJ4 | 32,210,203 | 36,665,000 | PRN | SOLE | NONE | 36,665,000 | 0 | 0 | |
| NUVASIVE INC | NOTE 1.000% 6/0 | 670704AL9 | 16,231,875 | 16,500,000 | PRN | SOLE | NONE | 16,500,000 | 0 | 0 | |
| NUVATION BIO INC | COM CL A | 67080N101 | 7,915,968 | 4,122,900 | SH | SOLE | NONE | 4,122,900 | 0 | 0 | |
| ORTHOPEDIATRICS CORP | COM | 68752L100 | 41,505,891 | 1,044,699 | SH | SOLE | NONE | 1,044,699 | 0 | 0 | |
| OUTSET MED INC | COM | 690145107 | 44,011,533 | 1,704,552 | SH | SOLE | NONE | 1,704,552 | 0 | 0 | |
| PENUMBRA INC | COM | 70975L107 | 36,222,717 | 162,828 | SH | SOLE | NONE | 162,828 | 0 | 0 | |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 10,122,298 | 927,800 | SH | SOLE | NONE | 927,800 | 0 | 0 | |
| PULMONX CORP | COM | 745848101 | 13,669,194 | 1,621,494 | SH | SOLE | NONE | 1,621,494 | 0 | 0 | |
| QUIDELORTHO CORP | COM | 219798105 | 25,738,438 | 300,437 | SH | SOLE | NONE | 300,437 | 0 | 0 | |
| RAPT THERAPEUTICS INC | COM | 75382E109 | 19,800,000 | 1,000,000 | SH | SOLE | NONE | 1,000,000 | 0 | 0 | |
| REPLIMUNE GROUP INC | COM | 76029N106 | 18,015,893 | 662,349 | SH | SOLE | NONE | 662,349 | 0 | 0 | |
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 18,186,812 | 140,352 | SH | SOLE | NONE | 140,352 | 0 | 0 | |
| SILK RD MED INC | COM | 82710M100 | 22,028,779 | 416,817 | SH | SOLE | NONE | 416,817 | 0 | 0 | |
| STERIS PLC | SHS USD | G8473T100 | 17,673,725 | 95,694 | SH | SOLE | NONE | 95,694 | 0 | 0 | |
| SUPERNUS PHARMACEUTICALS | NOTE 0.625% 4/0 | 868459AD0 | 6,418,750 | 6,500,000 | PRN | SOLE | NONE | 6,500,000 | 0 | 0 | |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 31,629,311 | 1,242,802 | SH | SOLE | NONE | 1,242,802 | 0 | 0 | |
| TRANSMEDICS GROUP INC | COM | 89377M109 | 18,712,578 | 303,185 | SH | SOLE | NONE | 303,185 | 0 | 0 | |
| TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 | 89422GAA5 | 2,745,000 | 3,000,000 | PRN | SOLE | NONE | 3,000,000 | 0 | 0 | |
| TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 46,649,782 | 50,536,000 | PRN | SOLE | NONE | 50,536,000 | 0 | 0 | |
| TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 | 89422GAA5 | 25,940,250 | 28,350,000 | PRN | SOLE | NONE | 28,350,000 | 0 | 0 | |
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | 30,610,953 | 1,455,585 | SH | SOLE | NONE | 1,455,585 | 0 | 0 | |
| VAXCYTE INC | COM | 92243G108 | 65,321,230 | 1,362,278 | SH | SOLE | NONE | 1,362,278 | 0 | 0 | |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 9,154,502 | 313,403 | SH | SOLE | NONE | 313,403 | 0 | 0 | |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 61,041,977 | 1,548,110 | SH | SOLE | NONE | 1,548,110 | 0 | 0 | |